EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD147‐K148me2‐Driven Tumor Cell‐Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis

Ke Wang iD, Xiaohong Chen, Peng Lin, Jiao Wu, Qiang Huang, Zhi-Nan Chen, Jiale Tian, Hao Wang, Ye Tian, Mingyan Shi, Meirui Qian, Bengang Hui und 7 weitere

Advanced Science · 2024-08 · 11 (29)

DOI: 10.1002/advs.202400611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 14.06.2024. Verfasst von Ke Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology of National Translational Science Center for Molecular Medicine and Department of Clinical Immunology of Xijing Hospital, …. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Basigin, Receptors, CCR5. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Science Fund Program for Distinguished Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunosuppression is a major hallmark of tumor progression in non‐small cell lung cancer (NSCLC). Cluster of differentiation 147 (CD147), an important pro‐tumorigenic factor, is closely linked to NSCLC immunosuppression. However, the role of CD147 di‐methylation in the immunosuppressive tumor microenvironment (TME) remains unclear. Here, di‐methylation of CD147 at Lys148 (CD147‐K148me2) is identified as a common post‐translational modification (PTM) in NSCLC that is significantly associated with unsatisfying survival outcomes among NSCLC sufferers, especially those in the advanced stages of the disease. The methyltransferase NSD2 catalyzes CD147 to generate CD147‐K148me2. Further analysis demonstrates that CD147‐K148me2 reestablishes the immunosuppressive TME and promotes NSCLC progression. Mechanistically, this modification promotes the interaction between cyclophilin A (CyPA) and CD147, and in turn, increases CCL5 gene transcription by activating p38‐ZBTB32 signaling, leading to increased NSCLC cell‐derived CCL5 secretion. Subsequently, CD147‐K148me2‐mediated CCL5 upregulation facilitates M2‐like tumor‐associated macrophage (TAM) infiltration in NSCLC tissues via CCL5/CCR5 axis‐dependent intercellular crosstalk between tumor cells and macrophages, which is inhibited by blocking CD147‐K148me2 with the targeted antibody 12C8. Overall, this study reveals the role of CD147‐K148me2‐driven intercellular crosstalk in the development of NSCLC immunosuppression, and provides a potential interventional strategy for PTM‐targeted NSCLC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsBasiginReceptors, CCR5Chemokine CCL5Tumor MicroenvironmentHumansMiceAnimalsMacrophagesCell Line, TumorImmunosuppression TherapyDisease Models, AnimalSignal Transduction

Stichwörter der Autor:innen

CCL5CD147‐K148me2NSD2non‐small cell lung cancertumor‐associated macrophages

Substanzen

BasiginReceptors, CCR5Chemokine CCL5CCR5 protein, humanBSG protein, humanCCL5 protein, human

Autor:innen und Institutionen

  • Department of Cell Biology of National Translational Science Center for Molecular Medicine and Department of Clinical Immunology of Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
  • State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, China.
  • School of Medicine, Shanghai University, Shanghai, 200444, China.
  • Department of Thoracic Surgery of Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, China.

ORCID-Profile: Ke Wang

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Science Fund Program for Distinguished Young Scholars
  • The Young Elite Scientist Sponsorship Program by China Association for Science and Technology
  • Science and Technology Project of Shaanxi Province, China
  • State Key Laboratory of Cancer Biology

Zitieren

APA

Wang, K., Chen, X., Lin, P., Wu, J., Huang, Q., Chen, Z. N., Tian, J., Wang, H., Tian, Y., Shi, M., Qian, M., Hui, B., Zhu, Y., Li, L., Yao, R., Bian, H., Zhu, P., Chen, R., & Chen, L. (2024). CD147‐K148me2‐Driven Tumor Cell‐Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis. Advanced Science, 11(29). https://doi.org/10.1002/advs.202400611

Vancouver

Wang K, Chen X, Lin P, Wu J, Huang Q, Chen ZN, et al. CD147‐K148me2‐Driven Tumor Cell‐Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis. Advanced Science. 2024;11(29). doi:10.1002/advs.202400611

BibTeX
@article{Wang2024,
  author = {Wang, Ke and Chen, Xiaohong and Lin, Peng and Wu, Jiao and Huang, Qiang and Chen, Zhi-Nan and Tian, Jiale and Wang, Hao and Tian, Ye and Shi, Mingyan and Qian, Meirui and Hui, Bengang and Zhu, Yumeng and Li, Ling and Yao, Rui and Bian, Huijie and Zhu, Ping and Chen, Ruo and Chen, Liang},
  title = {CD147‐K148me2‐Driven Tumor Cell‐Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {29},
  doi = {10.1002/advs.202400611}
}
Kostenlos starten →